Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat with Paclitaxel and Carboplatin in Ovarian Cancer
NCT00976183Phase 2Terminated
- Sponsor
- Gynecologic Oncology Associates
- Start
- Oct 2009
- Primary completion
- Jun 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Gynecologic Oncology Associates. Started Oct 2009; status: terminated.
02
Drugs
vorinostat
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00976183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976183.